Why Dietary Supplements Are the First Pathway for Cannabis Medicine
The cannabis industry has spent years waiting for this moment. As federal rescheduling moves forward, so do the opportunities to develop cannabinoid-based […]
The cannabis industry has spent years waiting for this moment. As federal rescheduling moves forward, so do the opportunities to develop cannabinoid-based […]
Cannabis packaging decisions have downstream consequences for compliance, operations, customer perception, and margins. This article offers a practical framework for evaluating packaging […]
As federal policymakers move toward restricting hemp-derived cannabinoid products, a new state-level effort in Colorado is taking the opposite approach by moving […]
As the U.S. hemp industry braces for potential federal disruption later this year, a new bipartisan bill aims to give states a […]
A letter to California’s Assembly Committee on Business and Professions argues a proposed 10mg THC-per-package cap would eliminate 93% of beverage sales […]
At the recent Business of Cannabis event in New York, Robert Sciarrone, Chief Revenue Officer at Curaleaf, shared an MSO’s insider view […]
California’s medical cannabis market began in 1996 when voters passed Proposition 215 (the Compassionate Use Act), making it the first state to […]
The Most Exciting US Market No cannabis market in the United States has experienced a more compelling growth trajectory over the past […]
As the cannabis industry continues to mature, labeling will continue to shape the way for product identification and consumer safety. Looking ahead […]
A decade ago, most banks wouldn’t touch a cannabis business. Whenever banking access came up, the discussion stopped almost immediately. People said […]